Clinical outcomes of prostate cancer patients detected by prostate-specific antigen-based population screening in Kanazawa City, Japan

International Journal of Urology

Volumn 18, Issue 8, 2011, Pages 592-596

  Kitagawa, Yasuhide ^a   Mizokami, Atsushi ^a   Nakashima, Kazuyoshi ^b   Koshida, Kiyoshi ^b   Shimamura, Masayoshi ^b   Miyazaki, Kimiomi ^b   Koyama, Nobu ^b   Namiki, Mikio ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b Kanazawa Medical Association   (Japan)

Author keywords

Clinical outcome; Prostate cancer; Prostate specific antigen based population screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; UROLOGY;

AGED; HUMANS; JAPAN; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; URBAN HEALTH;

EID: 79960636164     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2011.02796.x     Document Type: Article

References (17)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA. Cancer J. Clin. 1999; 49: 33-69.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA. Cancer J. Clin. 2009; 59: 225-49.
3. Bouchardy C, Fioretta G, Rapiti E etal. Recent trends in prostate cancer mortality show a continuous decrease in several countries. Int. J. Cancer 2008; 123: 421-29.
4. Ohno Y, Nakamura T, Murata K etal. Prediction of the future incidence of cancer in Japan. In: Oshima A, Kuroishi T, Tajima K (eds) White Paper on Cancer and Statistics-Incidence/Mortality/Prognosis-2004. Shinohara-Shuppan, Tokyo, 2004; 201-17 (in Japanese).
5. Kuroishi T, Hirose K, Tominaga Y etal. (eds) White Paper on Cancer and Statistics- Incidence/Mortality/Prognosis-2004. Shinohara-Shuppan, Tokyo, 2004; 219-34 (in Japanese).
6. Ito K. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives. Int. J. Urol. 2009; 16: 458-64.
7. Kobori Y, Kitagawa Y, Mizokami A, Komatsu K, Namiki M. Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1-10.0 ng/ml as a criterion. Int. J. Clin. Oncol. 2008; 13: 229-32.
8. International Union Against Cancer. Urologic tumors: prostate. In: Sobin LH, Wittekind CH (eds). TNM Classification of Malignant Tumours, 5th edn. John Wiley & Sons, New York, 1997; 170-3.
9. Schröder FH, Hugosson J, Roobol MJ etal. Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 2009; 360: 1320-28.
10. Bartsch G, Horninger W, Klocker H etal. Tyrol prostate cancer demonstration project: early detection, treatment, outcome, incidence and mortality. BJU Int. 2008; 101: 809-16.
11. Kubota Y, Ito K, Imai K, Yamanaka H. Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities. Prostate 2002; 50: 262-9.
12. Kato T, Habuchi T, Tsuchiya N, Sato K, Kitajima S, Kato S. Mass screening of prostate cancer and its impact on inhabitants in Akita prefecture, Japan. Aktuelle Urol. 2010; 41: 553-6.
13. Okihara K, Kitamura K, Okada K, Mikami K, Ukimura O, Miki T. Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan. Int. J. Urol. 2008; 15: 156-61.
14. Center for Cancer Control and Information Services, National Cancer Center, Japan. Cohort Table 2008. In: ganjoho.com. [Cited 5 Apr 2011.]. Available from URL:.
15. Smart CR. Prostate cancer facts and fiction. J. Surg. Oncol. 1997; 66: 223-29.
16. Ito K, Yamamoto T, Miyakubo M etal. Lead time of prostate cancer detected in population based screening for prostate cancer in Japan. J. Urol. 2007; 178: 1258-64.
17. Andoriole GL, Crawford D, Grubb RL III etal. Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 2009; 360: 1310-19.